Maternal Thyroid Deficiency during Pregnancy and Subsequent Neuropsychological Development of the Child
James E. Haddow, M.D., Glenn E. Palomaki, B.S., Walter C. Allan, M.D., Josephine R. Williams, George J. Knight, Ph.D., June Gagnon, M.A., Cheryl E. O'Heir, M.Ed., Ed.S., Marvin L. Mitchell, M.D., Rosalie J. Hermos, M.P.H., Susan E. Waisbren, Ph.D., James D. Faix, M.D., and Robert Z. Klein, M.D.
Background When thyroid deficiency occurs simultaneously ina pregnant woman and her fetus, the child's neuropsychologicaldevelopment is adversely affected. Whether developmental problemsoccur when only the mother has hypothyroidism during pregnancyis not known.
Methods In 1996 and 1997, we measured thyrotropin in storedserum samples collected from 25,216 pregnant women between January1987 and March 1990. We then located 47 women with serum thyrotropinconcentrations at or above the 99.7th percentile of the valuesfor all the pregnant women, 15 women with values between the98th and 99.6th percentiles, inclusive, in combination withlow thyroxine levels, and 124 matched women with normal values.Their seven-to-nine-year-old children, none of whom had hypothyroidismas newborns, underwent 15 tests relating to intelligence, attention,language, reading ability, school performance, and visual–motorperformance.
Results The children of the 62 women with high serum thyrotropinconcentrations performed slightly less well on all 15 tests.Their full-scale IQ scores on the Wechsler Intelligence Scalefor Children, third edition, averaged 4 points lower than thoseof the children of the 124 matched control women (P=0.06); 15percent had scores of 85 or less, as compared with 5 percentof the matched control children. Of the 62 women with thyroiddeficiency, 48 were not treated for the condition during thepregnancy under study. The full-scale IQ scores of their childrenaveraged 7 points lower than those of the 124 matched controlchildren (P=0.005); 19 percent had scores of 85 or less. Elevenyears after the pregnancy under study, 64 percent of the untreatedwomen and 4 percent of the matched control women had confirmedhypothyroidism.
Conclusions Undiagnosed hypothyroidism in pregnant women mayadversely affect their fetuses; therefore, screening for thyroiddeficiency during pregnancy may be warranted.
The link between hypothyroidism caused by iodine deficiencyduring pregnancy and mental retardation in the offspring hasbeen recognized for nearly 100 years.1 Iodine deficiency isassociated with thyroid deficiency in both mother and fetus,2a situation that makes it impossible to determine whether themental retardation of the fetus is due to maternal hypothyroidismor both maternal and fetal hypothyroidism. In developed countries,chronic autoimmune thyroiditis is the most common cause of hypothyroidismamong women in their childbearing years. Antibodies responsiblefor compromising maternal thyroid function can cross the placentaand, in some instances, compromise fetal and neonatal thyroidfunction.3,4,5,6,7,8 One such antibody, the thyrotropin-receptor–blockingantibody, has been implicated in cases of transient congenitalhypothyroidism that were identified by screening programs fornewborns.9
In 1969, Man and Jones suggested that mild maternal hypothyroidismalone was associated with lower IQ levels in the offspring;their study involved a cohort of 1349 children, and measurementsof serum butanol extractable iodine were used to distinguishbetween euthyroidism and hypothyroidism in women.8 A study byMatsuura and Konishi in 1990 documented that fetal brain developmentis adversely affected when both the mother and fetus have hypothyroidismcaused by chronic autoimmune thyroiditis.10 In such cases, transientneonatal hypothyroidism is present.
In an earlier, population-based survey of 2000 pregnancies,we measured serum thyrotropin concentrations during the secondtrimester.11 The concentrations were high (above 6 mU per liter)in 49 of the women, of whom 6 (3 per 1000) had low serum freethyroxine concentrations. If a lowering of the IQ levels ofthe offspring were to occur sufficiently often in associationwith this degree and frequency of maternal thyroid deficiency,then systematically determining the thyroid status of all womenbefore or very early in pregnancy might be justified. The aimof the current study was to determine whether undetected orinadequately treated maternal thyroid deficiency during pregnancyis associated with lower IQ scores in the offspring in the absenceof neonatal hypothyroidism.
Methods
The Foundation for Blood Research administers a statewide, second-trimesterprenatal serum screening program for open neural-tube defectsand Down's syndrome in Maine.12,13 Aliquots of serum that remainafter screening are routinely coded and stored at –20°C.Outcome information is available through a contract with thestate's Bureau of Vital Records. The current study cohort waslimited to women with viable singleton pregnancies, who werescreened between January 1987 and March 1990, and their infantswhose birth weight was at least 1500 g. The serum from the motherswas shipped to the New England Newborn Screening Program inBoston, where serum thyrotropin was measured. Samples from 25,216women were analyzed in five batches over a two-year period.
Selection of Women with Hypothyroidism and Control Subjects
We recruited women with hypothyroidism during pregnancy, asdetermined by a high serum thyrotropin concentration, withoutregard to treatment status, and we tested their children betweenMarch 1996 and December 1997. We contacted 55 of the 75 pregnantwomen with serum thyrotropin concentrations at or above the99.7th percentile of the values for all the pregnant women;47 (85 percent) agreed to participate. In 2 of the 75 pregnancies,the women were enrolled through a previous pregnancy. Of the18 women not contacted, 3 had moved to another state, 1 haddied, and for 1, the child was a ward of the state. The remaining13 were not contacted because of limited funds. At the urgingof a grant review panel, we recruited 18 more women to representa range of milder cases, defined by a serum thyrotropin concentrationbetween the 98th and 99.6th percentiles, inclusive, and a serumthyroxine concentration below 7.75 µg per deciliter (99.7nmol per liter). To identify this second subgroup, we measuredserum thyroxine concentrations in 247 pregnant women with serumthyrotropin concentrations between the 98th and 99.7th percentiles.Fifteen of the 18 women identified (83 percent) agreed to participate.After recruitment, we measured thyroxine, free thyroxine, andantithyroid peroxidase antibodies in the original serum samplesfrom all women in the study.
For each woman with hypothyroidism, we identified potentialcontrol subjects who had serum thyrotropin concentrations belowthe 98th percentile and who were matched according to the followingcriteria: mother's age at delivery (within one year), numberof years of education of the mother (within one year), gestationalage at the time of sampling (same completed week), durationof storage of serum sample (within one month), and sex of thechild. From this group, two women were randomly selected andrecruited for each woman with hypothyroidism. Additional matchedcontrol women were available from the same list, if one initiallydeclined participation.
The protocols for the additional assays and the follow-up studywere approved by the institutional review board at the Foundationfor Blood Research. Enrollment began with a telephone call tothe woman and a letter describing the study. Then an appointmentwas arranged, at which informed consent was requested and, ifconsent was granted, testing was performed on the child. Theneuropsychological test results were provided to the familywithin one month after the child's testing was completed.
At the end of the study, we contacted the women with hypothyroidismand the matched control women again to determine whether hypothyroidismhad been clinically diagnosed since the pregnancy in those whohad not received a diagnosis of hypothyroidism at the time ofpregnancy. The contact was initially by a letter, which alsoincluded information about the thyrotropin concentrations inthe stored serum samples. The letter was followed by a telephonecall, during which a questionnaire was administered and a bloodtest for measuring thyrotropin was offered. For those who agreedto be tested, blood spots were collected on filter paper bya finger prick.
Study Procedures
We collected standardized information about socioeconomic statusand medical history from all women enrolled in the study, usingthe Four Factor Index of Social Status (the Hollingshead score).14Each woman and her husband or partner were assigned an educationcode ranging from 1 (corresponding to less than seven yearsof schooling) to 7 (corresponding to graduate or professionaltraining) and an occupation code ranging from 1 (e.g., "farmworker") to 9 (e.g., "higher executive"). Each couple's individualeducation scores were multiplied by 3, the occupation scoreswere multiplied by 5, and the two values were then added together.The final score was the average of the scores of the woman andher partner. When one partner was not employed, the final scorewas taken to be the score of the employed partner. The womanwas also asked whether her child had repeated a grade and abouther child's school performance, including whether the childhad had learning problems or other difficulties in school.
Neuropsychological testing of the women's children includedassessment of intelligence, attention, language, reading ability,school performance, and visual–motor performance. Oneof two certified psychologists performed the testing, and theproject's consulting psychologist supervised the testing andrescored the tests. The staff involved in the neuropsychologicaltesting did not know whether the children's mothers were womenwith hypothyroidism or control women. Intelligence was measuredwith use of the Wechsler Intelligence Scale for Children, thirdedition,15 the most widely used intelligence test. This testprovides a full-scale IQ score and subscale scores (range, 40to 160) for verbal skills, performance, and freedom from distractibility.To measure hearing deficits in the children, the staff administeredsubtests on word discrimination and word articulation from theTest of Language Development, second edition16 (range of scores,1 to 20). We used the norms for children 8 years 11 months ofage, because the version for older children did not have scalesfor word discrimination or articulation. The Peabody IndividualAchievement Test, revised (PIAT-R),17 was used to measure readingrecognition and reading comprehension (range of scores, 55 to145).
The staff administered the Conners' Continuous Performance Testto measure sustained vigilance and attention,18 using a computerprogram that employs a go–no go paradigm (range of overallindex score, 1 to 30). The Developmental Test of Visual-MotorIntegration19 was administered to provide a standard measureof visual perception and fine motor skills (range, 55 to 145).The grooved pegboard test20 was administered to assess visual–motorcoordination and dexterity by measuring the time required toinsert pegs with both the preferred and nonpreferred hand (forthis test, it is recommended that normative data be derivedfrom control children in the study).
Assay Methods
We measured serum thyrotropin using a coated-tube radioimmunoassay(Diagnostic Products, Los Angeles). Thyrotropin was measuredon dried blood spots with a time-resolved immunofluorometricassay (Wallac Oy, Turku, Finland). Serum thyroxine was measuredwith a solid-phase radioimmunoassay21 or a time-resolved immunofluorometricassay (Wallac Oy); serum free thyroxine was measured with atime-resolved immunofluorometric assay. We measured serum antithyroidperoxidase antibodies using the Kalibre enzyme-linked immunosorbentassay (Kronus, San Clemente, Calif.) (normal concentration,2 U per milliliter).
Statistical Analysis
The serum thyrotropin, thyroxine, and free thyroxine concentrationswere logarithmically transformed before analysis. We used geometricmeans and logarithmic standard deviations to summarize the results(after censoring seven measurements that were more than 3 SDabove or below the group mean). We compared categorical variablesusing an exact test of significance or odds ratios, and we comparedcontinuous variables using the Student's t-test. When necessary,the t-test was modified to allow for unequal variances. Theprimary analysis was of all 62 women with hypothyroidism andall 124 control women; we preserved matching by comparing theresult from the child of a woman with hypothyroidism with theaverage result from the two matched control children. No adjustmentwas made for multiple comparisons. All statistical tests weretwo-sided.
Results
According to records from the New England Newborn ScreeningProgram, none of the children of the 62 women with high serumthyrotropin concentrations while pregnant were identified ashaving transient or permanent congenital hypothyroidism. Thedistribution of serum thyrotropin concentrations in the 62 womenwith hypothyroidism and the 124 matched control women is shownin Figure 1. Fifteen of the 62 women with hypothyroidism reportedthat they had received a diagnosis of hypothyroidism beforethe pregnancy, and 14 of these 15 women were treated for hypothyroidismduring that pregnancy. Two of the control women reported thatthey had had hypothyroidism in the distant past but were nevertreated.
Figure 1. Distribution of Serum Thyrotropin Concentrations during Pregnancy in the 62 Women with Hypothyroidism and the 124 Matched Control Women.
Open circles indicate the 14 women who were treated for hypothyroidism during the pregnancy under study. Selected percentiles are shown for the entire cohort of 25,216 pregnant women.
Demographic and pregnancy-related information about the womenwith hypothyroidism and the control women and the remainderof the cohort from which the women were selected is shown inTable 1. There were no significant differences between the womenwith hypothyroidism and the control women for any of the variables.Four of the variables were used for matching: number of yearsof education of the mother, mother's age at delivery, gestationalweek when the serum sample was obtained, and sex of the child.The use of the number of years of education as a matching variablewas intended to control for socioeconomic status. To assessthe effectiveness of this matching, we used the Hollingsheadscore as an additional measure. This score took into accountthe mother's educational level and occupation and also the father'seducational level and occupation. The mean Hollingshead scorein the women with hypothyroidism was one point lower than thatin the control women (P=0.43). The study children were similarin most respects to the remainder of the cohort, but more weregirls, their mothers were older, a higher percentage of theirmothers were married, and more of their mothers were multiparous.
Table 1. Characteristics of the Study Women, the Remainder of the Cohort, and Their Children.
The results of the measurements of thyroid function in the womenwith hypothyroidism and the control women during pregnancy areshown in Table 2. As expected, according to the selection process,the women with hypothyroidism had higher serum thyrotropin andlower serum thyroxine concentrations.
Table 2. Measurements of Thyroid Function in the Study Women during Pregnancy.
The children's neuropsychological test scores are shown in Table 3.All the children were between seven and nine years of agewhen tested, and the child of a woman with hypothyroidism andhis or her matched control children were tested at the sameage. The analysis preserved matching for each of the tests byexpressing the relative performance between case and controlchildren as a mean difference (the value in the case child minusthe average of the values in the two control children). Thecase children performed less well on all the tests; 2 of the15 differences reached statistical significance (P<0.05).
Table 3. Neuropsychological Test Scores among the Children of Women with Hypothyroidism during Pregnancy as Compared with the Children of Matched Control Women.
The results in the children were then grouped according to whetherthe mother's hypothyroidism was treated during the pregnancy(Table 4). The larger deficits in performance were found amongthe children of the untreated women; their scores for all 15tests were worse than those of the control children (their scoresfor 9 tests were significantly worse). Their average full-scaleIQ score on the Wechsler Intelligence Scale for Children, thirdedition, was 7 points lower, and 19 percent of the childrenof women with hypothyroidism had an IQ score of 85 or lower,as compared with 5 percent of the control children. The testscores of the children whose mothers were being treated (albeitinadequately) during pregnancy were similar to those of thecontrol children in most categories, even though the serum thyrotropinconcentrations were at or above the 99.7th percentile in 12of the 14 women. The serum thyroxine and free thyroxine concentrationsin the 14 treated women were very similar to the concentrationsin the 48 women with undiagnosed hypothyroidism.
Table 4. Neuropsychological Test Scores among the Children of Women with Hypothyroidism during Pregnancy as Compared with the Children of Matched Control Women, Stratified According to Whether the Hypothyroidism Was Being Treated.
The mean Hollingshead scores for the women who received treatment(48) and those who were not treated (44, or 45 if one low outlierwas removed) were similar, and these scores were similar tothose of the control women (46). A linear regression analysisof the full-scale intelligence score of the control childrenagainst the Hollingshead score of the control women indicatedthat there was an increase in intelligence of 0.4 point (95percent confidence interval, 0.2 to 0.7) for each 1-point increasein the Hollingshead score (P=0.002). Thus, the 2-point-highermean Hollingshead score of the treated women as compared withthat of the control women could account for a 0.8-point-higherIQ score of their children as compared with the control children,and the 2-point-lower mean Hollingshead score of the untreatedwomen could account for a 0.8-point-lower IQ score. Therefore,differences in maternal intelligence or socioeconomic statusmight account for only a small fraction of the differences shownin Table 4.
At the end of the study, we telephoned the women who were notknown to have hypothyroidism during pregnancy to determine whetherhypothyroidism had been clinically diagnosed subsequently; 120of the 124 control women and 45 of the 48 case women responded.Of those who responded, 5 (4 percent) of the control women and26 (58 percent) of the women with undiagnosed hypothyroidismduring pregnancy were now known to have hypothyroidism (oddsratio, 31; 95 percent confidence interval, 10 to 108). The medianinterval between pregnancy and clinical diagnosis was 5 years(range, 1 to 10). A total of 99 of the 115 control women whoidentified themselves as having normal thyroid function agreedto undergo follow-up testing; all the thyrotropin concentrationsin the blood spots were below 10 mU per liter. Fifteen of the19 women with hypothyroidism during pregnancy who identifiedthemselves as having normal thyroid function agreed to be tested;3 had high thyrotropin concentrations (14, 89, and 243 mU perliter). Altogether, 4 percent of the control women and 64 percentof the women with undiagnosed hypothyroidism during pregnancyhad confirmed hypothyroidism at the time of follow-up about11 years later.
Discussion
The current study shows that hypothyroidism in pregnant womencan adversely affect their children's subsequent performanceon neuropsychological tests. Decreases in performance can occureven when the pregnant woman's hypothyroidism is mild and probablyasymptomatic. The presence of high serum concentrations of antithyroidperoxidase antibodies in 77 percent of the women with hypothyroidismindicates that chronic autoimmune thyroiditis was the most frequentcause of hypothyroidism in these women. Treating maternal hypothyroidismduring pregnancy appears to be beneficial for the child, evenwhen treatment is inadequate as determined by measurements ofthyrotropin.
If our findings were to be confirmed, and routine screeningfor hypothyroidism during pregnancy were to be instituted, whatmight the benefits be? The main benefit — an increaseof approximately 4 points in IQ scores — would occur inthe children of women with serum thyrotropin concentrationsat or above the 98th percentile. A secondary benefit would bereduced morbidity for women who were systematically identifiedand treated. The present study shows that a large percentageof pregnant women with high serum thyrotropin concentrationssubsequently have clinically apparent hypothyroidism. Becausethe symptoms associated with hypothyroidism are nonspecific,the condition can be difficult to diagnose, as reflected bythe five-year median time to diagnosis in the women.
Before about 12 weeks' gestation, when the fetal thyroid glandbecomes active, the mother is the sole source of thyroid hormones.Maternal thyroid sufficiency might therefore be most importantin the first trimester. This theory is supported by a recentstudy in a small cohort of 220 healthy infants in which lowermaternal serum free thyroxine concentrations at 12 weeks' gestationwere associated with impaired psychomotor development at 10months of age.22 However, the later stages of fetal brain developmentinvolve neuronal migration and organization. Since these processesare responsible for functions measured by the neuropsychologicaltests used in the present study, thyroid insufficiency beyondthe first trimester is also likely to have adverse effects.23In rats, triiodothyronine receptors are first detected in thebrain in the second trimester, and the induction by triiodothyronineof enzymes that are important in nervous-system developmentbegins late in fetal development.24 The current study documentsa relatively long average interval between early biochemicalevidence of hypothyroidism and clinical diagnosis, a findingthat suggests that ongoing maternal health problems might hinderthe child's development after birth. In the absence of objectivedata, the most prudent policy would be to identify and treatmaternal hypothyroidism as early in pregnancy as possible, keepingin mind that the need for thyroxine increases during pregnancy.25
We conclude that systematic screening for hypothyroidism earlyin pregnancy may be worthwhile, even when the degree of deficiencyis mild and does not cause immediate clinical manifestationsin the woman. If routine screening were to be introduced, themost conservative policy would be to perform testing at thefirst prenatal visit, preferably in the first trimester. Follow-upof women with positive screening results would need to be prompt,so that treatment could begin quickly.
Supported by grants from the Thrasher Research Fund (02810-7),Knoll Pharmaceutical Company (SYN-0398-09), and the NationalInstitute of Child Health and Human Development (supplementto RO1-HD31183).
We are indebted to Professor Nicholas J. Wald of the WolfsonInstitute of Preventive Medicine, University of London, forstatistical advice and consultation; to Ms. Sonia Nelson forhelping to locate study participants; and to Ms. Penny Guerinfor her assistance in scheduling and data entry.
Source Information
From the Foundation for Blood Research, Scarborough, Me. (J.E.H., G.E.P., W.C.A., J.R.W., G.J.K., J.G., C.E.O.); the New England Newborn Screening Program, Jamaica Plain, Mass. (M.L.M., R.J.H.); Children's Hospital, Boston (S.E.W.); Beth Israel Deaconess Medical Center, Boston (J.D.F.); and Dartmouth Medical School, Hanover, N.H. (R.Z.K.).
Address reprint requests to Dr. Haddow at the Foundation for Blood Research, 69 U.S. Rte. 1, Scarborough, ME 04074.
References
Gardner LI. Historical notes on cretinism. In: Gardner LI, ed. Endocrine and genetic diseases of childhood and adolescence. 2nd ed. Philadelphia: W.B. Saunders, 1975:234-8.
Pharoah POD, Connolly KJ, Ekins RP, Harding AG. Maternal thyroid hormone levels in pregnancy and the subsequent cognitive and motor performance of the children. Clin Endocrinol (Oxf) 1984;21:265-270. [Medline]
Sutherland JM, Esselborn VM, Burket RL, Skillman TB, Benson JT. Familial nongoitrous cretinism apparently due to maternal antithyroid antibody: report of a family. N Engl J Med 1960;263:336-341. [Medline]
Connors HM, Styne DM. Transient neonatal "athyreosis" resulting from thyrotropin-binding inhibitory immunoglobulins. Pediatrics 1986;78:287-290. [Free Full Text]
Cho BY, Shong YK, Lee HK, Koh CS, Min HK, Lee M. Transient neonatal hypothyroidism due to transplacental transfer of maternal immunoglobulins that inhibit TSH binding, TSH-induced cAMP increase and cell growth. Endocrinol Jpn 1988;35:819-826. [Medline]
Fort P, Lifshitz F, Pugliese M, Klein I. Neonatal thyroid disease: differential expression in three successive offspring. J Clin Endocrinol Metab 1988;66:645-647. [Free Full Text]
Goldsmith RE, McAdams AJ, Larsen PR, McKenzie M, Hess EV. Familial autoimmune thyroiditis: maternal-fetal relationship and the role of generalized autoimmunity. J Clin Endocrinol Metab 1973;37:265-275. [Free Full Text]
Man EB, Jones WS. Thyroid function in human pregnancy. V. Incidence of maternal serum low butanol-extractable iodines and of normal gestational TBG and TBPA capacities: retardation of 8-month-old infants. Am J Obstet Gynecol 1969;104:898-908. [Medline]
Dussault JH, Fisher DA. Thyroid function in mothers of hypothyroid newborns. Obstet Gynecol 1999;93:15-20. [CrossRef][Medline]
Matsuura N, Konishi J. Transient hypothyroidism in infants born to mothers with chronic thyroiditis -- a nationwide study of twenty-three cases. Endocrinol Jpn 1990;37:369-379. [Erratum, Endocrinol Jpn 1990;37:767a.] [Medline]
Klein RZ, Haddow JE, Faix JD, et al. Prevalence of thyroid deficiency in pregnant women. Clin Endocrinol (Oxf) 1991;35:41-46. [Medline]
Haddow JE, Kloza EM, Smith DE, Knight GJ. Data from an alpha-fetoprotein pilot screening program in Maine. Obstet Gynecol 1983;62:556-560. [Medline]
Haddow JE, Palomaki GE, Knight GJ, et al. Prenatal screening for Down's syndrome with use of maternal serum markers. N Engl J Med 1992;327:588-593. [Abstract]
Hollingshead AB. Four factor index of social status. New Haven, Conn.: Yale University, 1975.
Wechsler D. Wechsler intelligence scale for children. 3rd ed. San Antonio, Tex.: Psychological, 1991.
Newcomer P, Hammill D. Test of language development — 2: intermediate. Austin, Tex.: PRO-ED, 1991.
Markwardt FC. Peabody individual achievement test. Rev. ed. Circle Pines, N.M.: American Guidance Service, 1989.
Beery KE. Developmental test of visual-motor integration. 2nd ed. Cleveland: Modern Curriculum Press, 1989.
Trites R. Grooved pegboard test. Lafayette, Ind.: Lafayette Instrument, 1989.
Mitchell ML. Improved thyroxine radioimmunoassay, for filter paper discs saturated with dried blood. Clin Chem 1976;22:1912-1914. [Free Full Text]
Pop VJ, Kuijpens JL, van Baar AL, et al. Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy. Clin Endocrinol (Oxf) 1999;50:149-155. [CrossRef][Medline]
Neuronal proliferation, migration, organization and myelination. In: Volpe JJ. Neurology of the newborn. 3rd ed. Philadelphia: W.B. Saunders, 1995:43-92.
Oppenheimer JH, Schwartz HL. Molecular basis of thyroid hormone-dependent brain development. Endocr Rev 1997;18:462-475. [Free Full Text]
Mandel SJ, Larsen PR, Seely EW, Brent GA. Increased need for thyroxine during pregnancy in women with primary hypothyroidism. N Engl J Med 1990;323:91-96. [Abstract]
Boas, M., Forman, J. L., Juul, A., Feldt-Rasmussen, U., Skakkebaek, N. E., Hilsted, L., Chellakooty, M., Larsen, T., Larsen, J. F., Petersen, J. H, Main, K. M
(2009). Narrow intra-individual variation of maternal thyroid function in pregnancy based on a longitudinal study on 132 women. Eur J Endocrinol
161: 903-910
[Abstract][Full Text]
Levine, R. J, Vatten, L. J, Horowitz, G. L, Qian, C., Romundstad, P. R, Yu, K. F, Hollenberg, A. N, Hellevik, A. I, Asvold, B. O, Karumanchi, S A.
(2009). Pre-eclampsia, soluble fms-like tyrosine kinase 1, and the risk of reduced thyroid function: nested case-control and population based study. BMJ
339: b4336-b4336
[Abstract][Full Text]
Shields, B. M., Freathy, R. M., Knight, B. A., Hill, A., Weedon, M. N., Frayling, T. M., Hattersley, A. T., Vaidya, B.
(2009). Phosphodiesterase 8B Gene Polymorphism Is Associated with Subclinical Hypothyroidism in Pregnancy. J. Clin. Endocrinol. Metab.
94: 4608-4612
[Abstract][Full Text]
Flippin, J. L., Hedge, J. M., DeVito, M. J., LeBlanc, G. A., Crofton, K. M.
(2009). Predictive Modeling of a Mixture of Thyroid Hormone Disrupting Chemicals That Affect Production and Clearance of Thyroxine. International Journal of Toxicology
28: 368-381
[Abstract][Full Text]
Wirth, E. K., Roth, S., Blechschmidt, C., Holter, S. M., Becker, L., Racz, I., Zimmer, A., Klopstock, T., Gailus-Durner, V., Fuchs, H., Wurst, W., Naumann, T., Brauer, A., Hrabe de Angelis, M., Kohrle, J., Gruters, A., Schweizer, U.
(2009). Neuronal 3',3,5-Triiodothyronine (T3) Uptake and Behavioral Phenotype of Mice Deficient in Mct8, the Neuronal T3 Transporter Mutated in Allan-Herndon-Dudley Syndrome. J. Neurosci.
29: 9439-9449
[Abstract][Full Text]
Talsness, C. E., Andrade, A. J. M., Kuriyama, S. N., Taylor, J. A., vom Saal, F. S.
(2009). Components of plastic: experimental studies in animals and relevance for human health. Phil Trans R Soc B
364: 2079-2096
[Abstract][Full Text]
Benhadi, N, Wiersinga, W M, Reitsma, J B, Vrijkotte, T G M, Bonsel, G J
(2009). Higher maternal TSH levels in pregnancy are associated with increased risk for miscarriage, fetal or neonatal death. Eur J Endocrinol
160: 985-991
[Abstract][Full Text]
Zimmermann, M. B.
(2009). Iodine Deficiency. Endocr. Rev.
30: 376-408
[Abstract][Full Text]
Springer, D., Zima, T., Limanova, Z.
(2009). Reference intervals in evaluation of maternal thyroid function during the first trimester of pregnancy. Eur J Endocrinol
160: 791-797
[Abstract][Full Text]
Orito, Y., Oku, H., Kubota, S., Amino, N., Shimogaki, K., Hata, M., Manki, K., Tanaka, Y., Sugino, S., Ueta, M., Kawakita, K., Nunotani, T., Tatsumi, N., Ichihara, K., Miyauchi, A., Miyake, M.
(2009). Thyroid Function in Early Pregnancy in Japanese Healthy Women: Relation to Urinary Iodine Excretion, Emesis, and Fetal and Child Development. J. Clin. Endocrinol. Metab.
94: 1683-1688
[Abstract][Full Text]
James, S. R., Franklyn, J. A., Reaves, B. J., Smith, V. E., Chan, S. Y., Barrett, T. G., Kilby, M. D., McCabe, C. J.
(2009). Monocarboxylate Transporter 8 in Neuronal Cell Growth. Endocrinology
150: 1961-1969
[Abstract][Full Text]
Mannisto, T., Vaarasmaki, M., Pouta, A., Hartikainen, A.-L., Ruokonen, A., Surcel, H.-M., Bloigu, A., Jarvelin, M.-R., Suvanto-Luukkonen, E.
(2009). Perinatal Outcome of Children Born to Mothers with Thyroid Dysfunction or Antibodies: A Prospective Population-Based Cohort Study. J. Clin. Endocrinol. Metab.
94: 772-779
[Abstract][Full Text]
Alvarez-Pedrerol, M, Guxens, M, Mendez, M, Canet, Y, Martorell, R, Espada, M, Plana, E, Rebagliato, M, Sunyer, J
(2009). Iodine levels and thyroid hormones in healthy pregnant women and birth weight of their offspring. Eur J Endocrinol
160: 423-429
[Abstract][Full Text]
Oken, E., Braverman, L. E., Platek, D., Mitchell, M. L., Lee, S. L., Pearce, E. N.
(2009). Neonatal Thyroxine, Maternal Thyroid Function, and Child Cognition. J. Clin. Endocrinol. Metab.
94: 497-503
[Abstract][Full Text]
Zimmermann, M. B
(2009). Iodine deficiency in pregnancy and the effects of maternal iodine supplementation on the offspring: a review. Am. J. Clin. Nutr.
89: 668S-672S
[Abstract][Full Text]
Stagnaro-Green, A.
(2009). Maternal Thyroid Disease and Preterm Delivery. J. Clin. Endocrinol. Metab.
94: 21-25
[Abstract][Full Text]
Zorrilla, L. M., Gibson, E. K., Jeffay, S. C., Crofton, K. M., Setzer, W. R., Cooper, R. L., Stoker, T. E.
(2009). The Effects of Triclosan on Puberty and Thyroid Hormones in Male Wistar Rats. Toxicol Sci
107: 56-64
[Abstract][Full Text]
Fatourechi, V.
(2009). Subclinical Hypothyroidism: An Update for Primary Care Physicians. Mayo Clin Proc.
84: 65-71
[Abstract][Full Text]
Peri, A., Serio, M.
(2008). Neuroprotective effects of the Alzheimer's disease-related gene seladin-1. J Mol Endocrinol
41: 251-261
[Abstract][Full Text]
Maruo, Y., Takahashi, H., Soeda, I., Nishikura, N., Matsui, K., Ota, Y., Mimura, Y., Mori, A., Sato, H., Takeuchi, Y.
(2008). Transient Congenital Hypothyroidism Caused by Biallelic Mutations of the Dual Oxidase 2 Gene in Japanese Patients Detected by a Neonatal Screening Program. J. Clin. Endocrinol. Metab.
93: 4261-4267
[Abstract][Full Text]
Girling, J.
(2008). Thyroid disease in pregnancy. The Obstetrician and Gynaecologist
10: 237-243
[Abstract][Full Text]
Sinha, R. A., Pathak, A., Mohan, V., Bandyopadhyay, S., Rastogi, L., Godbole, M. M.
(2008). Maternal Thyroid Hormone: A Strong Repressor of Neuronal Nitric Oxide Synthase in Rat Embryonic Neocortex. Endocrinology
149: 4396-4401
[Abstract][Full Text]
Chevrier, J., Eskenazi, B., Holland, N., Bradman, A., Barr, D. B.
(2008). Effects of Exposure to Polychlorinated Biphenyls and Organochlorine Pesticides on Thyroid Function during Pregnancy. Am J Epidemiol
168: 298-310
[Abstract][Full Text]
Bravender, T.
(2008). School Performance: The Pediatrician's Role. CLIN PEDIATR
47: 535-545
[Abstract]
Dosiou, C., Sanders, G. D, Araki, S. S, Crapo, L. M
(2008). Screening pregnant women for autoimmune thyroid disease: a cost-effectiveness analysis.. Eur J Endocrinol
158: 841-851
[Abstract][Full Text]
Benvenuti, S, Luciani, P, Cellai, I, Deledda, C, Baglioni, S, Saccardi, R, Urbani, S, Francini, F, Squecco, R, Giuliani, C, Vannelli, G B, Serio, M, Pinchera, A, Peri, A
(2008). Thyroid hormones promote cell differentiation and up-regulate the expression of the seladin-1 gene in in vitro models of human neuronal precursors. J Endocrinol
197: 437-446
[Abstract][Full Text]
Jansen, J., Friesema, E. C. H., Kester, M. H. A., Schwartz, C. E., Visser, T. J.
(2008). Genotype-Phenotype Relationship in Patients with Mutations in Thyroid Hormone Transporter MCT8. Endocrinology
149: 2184-2190
[Abstract][Full Text]
Wasserman, E. E., Nelson, K., Rose, N. R., Eaton, W., Pillion, J. P., Seaberg, E., Talor, M. V., Burek, L., Duggan, A., Yolken, R. H.
(2008). Maternal Thyroid Autoantibodies during the Third Trimester and Hearing Deficits in Children: An Epidemiologic Assessment. Am J Epidemiol
167: 701-710
[Abstract][Full Text]
Biondi, B., Cooper, D. S.
(2008). The Clinical Significance of Subclinical Thyroid Dysfunction. Endocr. Rev.
29: 76-131
[Abstract][Full Text]
Stricker, R., Echenard, M, Eberhart, R, Chevailler, M-C, Perez, V, Quinn, F A, Stricker, R.
(2007). Evaluation of maternal thyroid function during pregnancy: the importance of using gestational age-specific reference intervals. Eur J Endocrinol
157: 509-514
[Abstract][Full Text]
Huang, P.-C., Kuo, P.-L., Guo, Y.-L., Liao, P.-C., Lee, C.-C.
(2007). Associations between urinary phthalate monoesters and thyroid hormones in pregnant women. Hum Reprod
22: 2715-2722
[Abstract][Full Text]
Zimmermann, M. B., Burgi, H., Hurrell, R. F.
(2007). Iron Deficiency Predicts Poor Maternal Thyroid Status during Pregnancy. J. Clin. Endocrinol. Metab.
92: 3436-3440
[Abstract][Full Text]
Glinoer, D., Abalovich, M.
(2007). Unresolved questions in managing hypothyroidism during pregnancy. BMJ
335: 300-302
[Full Text]
Abalovich, M., Amino, N., Barbour, L. A., Cobin, R. H., De Groot, L. J., Glinoer, D., Mandel, S. J., Stagnaro-Green, A.
(2007). Management of Thyroid Dysfunction during Pregnancy and Postpartum: An Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab.
92: s1-s47
[Abstract][Full Text]
Goodman, J. H., Gilbert, M. E.
(2007). Modest Thyroid Hormone Insufficiency during Development Induces a Cellular Malformation in the Corpus Callosum: A Model of Cortical Dysplasia. Endocrinology
148: 2593-2597
[Abstract][Full Text]
Kempers, M. J. E., van der Sluijs Veer, L., Nijhuis-van der Sanden, R. W. G., Lanting, C. I., Kooistra, L., Wiedijk, B. M., Last, B. F., de Vijlder, J. J. M., Grootenhuis, M. A., Vulsma, T.
(2007). Neonatal Screening for Congenital Hypothyroidism in The Netherlands: Cognitive and Motor Outcome at 10 Years of Age. J. Clin. Endocrinol. Metab.
92: 919-924
[Abstract][Full Text]
Brent, G. A.
(2007). Diagnosing Thyroid Dysfunction in Pregnant Women: Is Case Finding Enough?. J. Clin. Endocrinol. Metab.
92: 39-41
[Full Text]
Vaidya, B., Anthony, S., Bilous, M., Shields, B., Drury, J., Hutchison, S., Bilous, R.
(2007). Detection of Thyroid Dysfunction in Early Pregnancy: Universal Screening or Targeted High-Risk Case Finding?. J. Clin. Endocrinol. Metab.
92: 203-207
[Abstract][Full Text]
Kajantie, E., Phillips, D. I. W., Osmond, C., Barker, D. J. P., Forsen, T., Eriksson, J. G.
(2006). Spontaneous Hypothyroidism in Adult Women Is Predicted by Small Body Size at Birth and during Childhood. J. Clin. Endocrinol. Metab.
91: 4953-4956
[Abstract][Full Text]
Pearce, E. N., Hollowell, J. G. Jr., Morreale de Escobar, G., Escobar del Rey, F., Utiger, R. D.
(2006). Iodine Nutrition -- More Is Better. NEJM
355: 1500-1501
[Full Text]
Premawardhana, L D K E, Lazarus, J H
(2006). Management of thyroid disorders.. Postgrad. Med. J.
82: 552-558
[Abstract][Full Text]
De Groef, B., Decallonne, B. R, Van der Geyten, S., Darras, V. M, Bouillon, R.
(2006). Perchlorate versus other environmental sodium/iodide symporter inhibitors: potential thyroid-related health effects.. Eur J Endocrinol
155: 17-25
[Abstract][Full Text]
Johnson, J. L.
(2006). Diabetes Control in Thyroid Disease. Diabetes Spectr.
19: 148-153
[Abstract][Full Text]
Negro, R., Formoso, G., Mangieri, T., Pezzarossa, A., Dazzi, D., Hassan, H.
(2006). Levothyroxine Treatment in Euthyroid Pregnant Women with Autoimmune Thyroid Disease: Effects on Obstetrical Complications. J. Clin. Endocrinol. Metab.
91: 2587-2591
[Abstract][Full Text]
Chan, S-Y, Franklyn, J A, Pemberton, H N, Bulmer, J N, Visser, T J, McCabe, C J, Kilby, M D
(2006). Monocarboxylate transporter 8 expression in the human placenta: the effects of severe intrauterine growth restriction.. J Endocrinol
189: 465-471
[Abstract][Full Text]
American Academy of Pediatrics, , Rose, S. R., and the Section on Endocrinology and Committee on, , American Thyroid Association, , Brown, R. S., and the Public Health Committee, , Lawson Wilkins Pediatric Endocrine Society,
(2006). Update of newborn screening and therapy for congenital hypothyroidism.. Pediatrics
117: 2290-2303
[Abstract][Full Text]
Visser, T. J.
(2006). The elemental importance of sufficient iodine intake: a trace is not enough.. Endocrinology
147: 2095-2097
[Full Text]
McKinnon, B., Li, H., Richard, K., Mortimer, R.
(2005). Synthesis of Thyroid Hormone Binding Proteins Transthyretin and Albumin by Human Trophoblast. J. Clin. Endocrinol. Metab.
90: 6714-6720
[Abstract][Full Text]
York, R. G., Lewis, E., Brown, W. R., Girard, M. F., Mattie, D. R., Funk, K. A., Strawson, J. S.
(2005). Refining the Effects Observed in a Developmental Neurobehavioral Study of Ammonium Perchlorate Administered Orally in Drinking Water to Rats. I. Thyroid and Reproductive Effects. International Journal of Toxicology
24: 403-418
[Abstract][Full Text]
Wartofsky, L.
(2005). Update in Endocrinology. ANN INTERN MED
143: 673-682
[Full Text]
Boelaert, K, Franklyn, J A
(2005). Thyroid hormone in health and disease. J Endocrinol
187: 1-15
[Abstract][Full Text]
Chan, S. Y, Andrews, M. H, Lingas, R., McCabe, C. J, Franklyn, J. A, Kilby, M. D, Matthews, S. G
(2005). Maternal nutrient deprivation induces sex-specific changes in thyroid hormone receptor and deiodinase expression in the fetal guinea pig brain. J. Physiol.
566: 467-480
[Abstract][Full Text]
van Trotsenburg, A. S. P., Vulsma, T., van Rozenburg-Marres, S. L. R., van Baar, A. L., Ridder, J. C. D., Heymans, H. S. A., Tijssen, J. G. P., de Vijlder, J. J. M.
(2005). The Effect of Thyroxine Treatment Started in the Neonatal Period on Development and Growth of Two-Year-Old Down Syndrome Children: A Randomized Clinical Trial. J. Clin. Endocrinol. Metab.
90: 3304-3311
[Abstract][Full Text]
Lazarus, J H, Premawardhana, L D K E
(2005). BEST PRACTICE NO 184 Screening for thyroid disease in pregnancy. J. Clin. Pathol.
58: 449-452
[Abstract][Full Text]
Sui, L., Anderson, W. L., Gilbert, M. E.
(2005). Impairment in Short-Term but Enhanced Long-Term Synaptic Potentiation and ERK Activation in Adult Hippocampal Area CA1 Following Developmental Thyroid Hormone Insufficiency*. Toxicol Sci
85: 647-656
[Abstract][Full Text]
Zoeller, R. T., Bansal, R., Parris, C.
(2005). Bisphenol-A, an Environmental Contaminant that Acts as a Thyroid Hormone Receptor Antagonist in Vitro, Increases Serum Thyroxine, and Alters RC3/Neurogranin Expression in the Developing Rat Brain. Endocrinology
146: 607-612
[Abstract][Full Text]
Chang, A. Y., Chamberlain-Shea, H., Carr, B.
(2005). Fetal Loss Associated With Excess Thyroid Hormone Exposure. JAMA
293: 160-161
[Full Text]
Gharib, H., Tuttle, R. M., Baskin, H. J., Fish, L. H., Singer, P. A., McDermott, M. T.
(2005). Subclinical Thyroid Dysfunction: A Joint Statement on Management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and The Endocrine Society. J. Clin. Endocrinol. Metab.
90: 581-585
[Full Text]
Vermiglio, F., Lo Presti, V. P., Moleti, M., Sidoti, M., Tortorella, G., Scaffidi, G., Castagna, M. G., Mattina, F., Violi, M. A., Crisa, A., Artemisia, A., Trimarchi, F.
(2004). Attention Deficit and Hyperactivity Disorders in the Offspring of Mothers Exposed to Mild-Moderate Iodine Deficiency: A Possible Novel Iodine Deficiency Disorder in Developed Countries. J. Clin. Endocrinol. Metab.
89: 6054-6060
[Abstract][Full Text]
(2004). Thyroid Disorders: Effects on Reproductive Health. JWatch Women's Health
2004: 5-5
[Full Text]
Forrest, D.
(2004). The Developing Brain and Maternal Thyroid Hormone: Finding the Links. Endocrinology
145: 4034-4036
[Full Text]
Auso, E., Lavado-Autric, R., Cuevas, E., del Rey, F. E., Morreale de Escobar, G., Berbel, P.
(2004). A Moderate and Transient Deficiency of Maternal Thyroid Function at the Beginning of Fetal Neocorticogenesis Alters Neuronal Migration. Endocrinology
145: 4037-4047
[Abstract][Full Text]
Kibirige, M S, Hutchison, S, Owen, C J, Delves, H T
(2004). Prevalence of maternal dietary iodine insufficiency in the north east of England: implications for the fetus. Arch. Dis. Child. Fetal Neonatal Ed.
89: F436-F439
[Abstract][Full Text]
Poppe, K., Glinoer, D., Tournaye, H., Schiettecatte, J., Devroey, P., van Steirteghem, A., Haentjens, P., Velkeniers, B.
(2004). Impact of Ovarian Hyperstimulation on Thyroid Function in Women with and without Thyroid Autoimmunity. J. Clin. Endocrinol. Metab.
89: 3808-3812
[Abstract][Full Text]
Gereben, B., Pachucki, J., Kollar, A., Liposits, Z., Fekete, C.
(2004). Ontogenic Redistribution of Type 2 Deiodinase Messenger Ribonucleic Acid in the Brain of Chicken. Endocrinology
145: 3619-3625
[Abstract][Full Text]
Slone Wilcoxon, J., Redei, E. E.
(2004). Prenatal programming of adult thyroid function by alcohol and thyroid hormones. Am. J. Physiol. Endocrinol. Metab.
287: E318-E326
[Abstract][Full Text]
Alexander, E. K., Marqusee, E., Lawrence, J., Jarolim, P., Fischer, G. A., Larsen, P. R.
(2004). Timing and Magnitude of Increases in Levothyroxine Requirements during Pregnancy in Women with Hypothyroidism. NEJM
351: 241-249
[Abstract][Full Text]
Toft, A.
(2004). Increased Levothyroxine Requirements in Pregnancy -- Why, When, and How Much?. NEJM
351: 292-294
[Full Text]
Zoeller, R. T.
(2004). Editorial: Local Control of the Timing of Thyroid Hormone Action in the Developing Human Brain. J. Clin. Endocrinol. Metab.
89: 3114-3116
[Full Text]
Kester, M. H. A., Martinez de Mena, R., Jesus Obregon, M., Marinkovic, D., Howatson, A., Visser, T. J., Hume, R., Morreale de Escobar, G.
(2004). Iodothyronine Levels in the Human Developing Brain: Major Regulatory Roles of Iodothyronine Deiodinases in Different Areas. J. Clin. Endocrinol. Metab.
89: 3117-3128
[Abstract][Full Text]
York, R. G., Barnett, J. Jr., Brown, W. R., Garman, R. H., Mattie, D. R., Dodd, D.
(2004). A Rat Neurodevelopmental Evaluation of Offspring, Including Evaluation of Adult and Neonatal Thyroid, from Mothers Treated with Ammonium Perchlorate in Drinking Water. International Journal of Toxicology
23: 191-214
[Abstract][Full Text]
Hujoel, P. P., Bollen, A.-M., Noonan, C. J., del Aguila, M. A.
(2004). Antepartum Dental Radiography and Infant Low Birth Weight. JAMA
291: 1987-1993
[Abstract][Full Text]
Weiss, B., Amler, S., Amler, R. W.
(2004). Pesticides. Pediatrics
113: 1030-1036
[Abstract][Full Text]
Rodien, P., Jordan, N., Lefevre, A., Royer, J., Vasseur, C., Savagner, F., Bourdelot, A., Rohmer, V.
(2004). Abnormal stimulation of the thyrotrophin receptor during gestation. Hum Reprod Update
10: 95-105
[Abstract][Full Text]
Surks, M. I., Ortiz, E., Daniels, G. H., Sawin, C. T., Col, N. F., Cobin, R. H., Franklyn, J. A., Hershman, J. M., Burman, K. D., Denke, M. A., Gorman, C., Cooper, R. S., Weissman, N. J.
(2004). Subclinical Thyroid Disease: Scientific Review and Guidelines for Diagnosis and Management. JAMA
291: 228-238
[Abstract][Full Text]
Col, N. F., Surks, M. I., Daniels, G. H.
(2004). Subclinical Thyroid Disease: Clinical Applications. JAMA
291: 239-243
[Abstract][Full Text]
Kempers, M. J. E., van Tijn, D. A., van Trotsenburg, A. S. P., de Vijlder, J. J. M., Wiedijk, B. M., Vulsma, T.
(2003). Central Congenital Hypothyroidism due to Gestational Hyperthyroidism: Detection Where Prevention Failed. J. Clin. Endocrinol. Metab.
88: 5851-5857
[Abstract][Full Text]
York, R. G., Funk, K. A., Girard, M. F., Mattie, D., Strawson, J. E.
(2003). Oral (Drinking Water) Developmental Toxicity Study of Ammonium Perchlorate in Sprague-Dawley Rats. International Journal of Toxicology
22: 453-464
[Abstract]
Carvalho, D. P.
(2003). Modulation of Uterine Iodothyronine Deiodinases--A Critical Event for Fetal Development?. Endocrinology
144: 4250-4252
[Full Text]
Siddiqi, M. A., Laessig, R. H., Reed, K. D.
(2003). Polybrominated Diphenyl Ethers (PBDEs): New Pollutants-Old Diseases. Clin Med Res
1: 281-290
[Abstract][Full Text]
Chan, S., Kachilele, S., Hobbs, E., Bulmer, J. N., Boelaert, K., McCabe, C. J., Driver, P. M., Bradwell, A. R., Kester, M., Visser, T. J., Franklyn, J. A., Kilby, M. D.
(2003). Placental Iodothyronine Deiodinase Expression in Normal and Growth-Restricted Human Pregnancies. J. Clin. Endocrinol. Metab.
88: 4488-4495
[Abstract][Full Text]
Thibodeaux, J. R., Hanson, R. G., Rogers, J. M., Grey, B. E., Barbee, B. D., Richards, J. H., Butenhoff, J. L., Stevenson, L. A., Lau, C.
(2003). Exposure to Perfluorooctane Sulfonate during Pregnancy in Rat and Mouse. I: Maternal and Prenatal Evaluations. Toxicol Sci
74: 369-381
[Abstract][Full Text]
Clewell, R. A., Merrill, E. A., Yu, K. O., Mahle, D. A., Sterner, T. R., Fisher, J. W., Gearhart, J. M.
(2003). Predicting Neonatal Perchlorate Dose and Inhibition of Iodide Uptake in the Rat during Lactation Using Physiologically-Based Pharmacokinetic Modeling. Toxicol Sci
74: 416-436
[Abstract][Full Text]
Clewell, R. A., Merrill, E. A., Yu, K. O., Mahle, D. A., Sterner, T. R., Mattie, D. R., Robinson, P. J., Fisher, J. W., Gearhart, J. M.
(2003). Predicting Fetal Perchlorate Dose and Inhibition of Iodide Kinetics during Gestation: A Physiologically-Based Pharmacokinetic Analysis of Perchlorate and Iodide Kinetics in the Rat. Toxicol Sci
73: 235-255
[Abstract][Full Text]
Clarkson, T. W., Strain, J. J.
(2003). Nutritional Factors May Modify the Toxic Action of Methyl Mercury in Fish-Eating Populations. J. Nutr.
133: 1539S-1543
[Abstract][Full Text]
Mahle, D. A., Yu, K. O., Narayanan, L., Mattie, D. R., Fisher, J. W.
(2003). Changes in Cross-Fostered Sprague-Dawley Rat Litters Exposed to Perchlorate. International Journal of Toxicology
22: 87-94
[Abstract]
Ogilvy-Stuart, A L
(2002). Neonatal thyroid disorders. Arch. Dis. Child. Fetal Neonatal Ed.
87: F165-171
[Abstract][Full Text]
Stagnaro-Green, A.
(2002). Postpartum Thyroiditis. J. Clin. Endocrinol. Metab.
87: 4042-4047
[Full Text]
Moreno, J. C., Bikker, H., Kempers, M. J.E., van Trotsenburg, A.S. P., Baas, F., de Vijlder, J. J.M., Vulsma, T., Ris-Stalpers, C.
(2002). Inactivating Mutations in the Gene for Thyroid Oxidase 2 (THOX2) and Congenital Hypothyroidism. NEJM
347: 95-102
[Abstract][Full Text]
Cahill, D J, Wardle, P G
(2002). Management of infertility. BMJ
325: 28-32
[Full Text]
Forrest, D.
(2002). Editorial: Twists in the Tail--Change-of-Function Mutations in Thyroid Hormone Receptors. Endocrinology
143: 2466-2468
[Full Text]
Liu, Y.-Y., Tachiki, K. H., Brent, G. A.
(2002). A Targeted Thyroid Hormone Receptor {alpha} Gene Dominant-Negative Mutation (P398H) Selectively Impairs Gene Expression in Differentiated Embryonic Stem Cells. Endocrinology
143: 2664-2672
[Abstract][Full Text]
Fenton, S. E., Hamm, J. T., Birnbaum, L. S., Youngblood, G. L.
(2002). Persistent Abnormalities in the Rat Mammary Gland following Gestational and Lactational Exposure to 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD). Toxicol Sci
67: 63-74
[Abstract][Full Text]
Calvo, R. M., Jauniaux, E., Gulbis, B., Asuncion, M., Gervy, C., Contempre, B., Morreale de Escobar, G.
(2002). Fetal Tissues Are Exposed to Biologically Relevant Free Thyroxine Concentrations during Early Phases of Development. J. Clin. Endocrinol. Metab.
87: 1768-1777
[Abstract][Full Text]
A correction has been published: N Engl J Med 1999;341(26):2015.
2 U per milliliter). 
